Management Team

Ebrahim S. Delpassand, MD

Founder & Chairman of the Board/ CEO of RadioMedix (2006)

• Board certified nuclear medicine physician

• Former Deputy Chair and Chief of Clinical Nuclear Medicine MD. Anderson Cancer Center

• Founder & Chariman of Excel Diagnostics & Nuclear Oncology Center (2003)

• PI/Sponsor of current five INDs

• Adjunct professor, Department of Radiation Oncology, UT and Nuclear Medicine at BCM in

Houston.

• Co-Founder of Infinity Care (home healthcare company) and Infinity Infusion Care.

• Executed exit strategy for acquisition of Infinity Infusion Care by Curative Healthcare in 2002.

Chief Scientific Officer

Co-Founder & Board Member

M.S.Pharm (Clinical), Medical University, Poland
Ph.D. (Chemistry), Centre of Molecular and Macromolecular Studies, Polish Academy of Science
J.W. Goethe Frankfurt University, Germany
William Rice Fellowship (Biochemistry), Rice University (Houston)

• +25 years experience in the clinical pharmacy and chemistry

• +13 years experience in oncology research

• International awards: IUPAC and Sigma Aldrich Award

• Expertise: CMC and pre-clinical evaluation of radiotheranostics drugs ( 4 INDs )

• Principal Investigator: 5 SBIR Phase I/II awards

• Co-author of +30 peer-review papers

• Member NIH/NCI study section and Leader AlphaMedix project

• Strategic and regulatory support of INDs and DMF

• Strategic planning for CMC, Non-Clinical, Clinical, Pharmacology, Drug Safety,

Clinical Operations, Data Management, Biostatistics and Medical Writing to

support FDA submissions

• Experienced in Regulatory Operations to ensure quality of submissions meet FDA standard